Gut microbiota-derived riboflavin mediates protective effects of MUC2 in acute pancreatitis via CD40-macrophage pathway
Authors:
Open Access
- 12 August 2026
- journal article
- research article
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Abstract
Gut barrier dysfunction is critical in the pathogenesis of acute pancreatitis (AP), yet the underlying mechanisms remain unclear. Mucin 2 (MUC2), the primaKeywords
Funding Information
- National Natural Science Foundation of China (82270671)
- Shanghai General Hospital (CCTR-2022B02)
- Shanghai Municipal Health Commission (202440170)
This publication has 56 references indexed in Scilit:
- Gut microbiota controls the development of chronic pancreatitis: A critical role of short-chain fatty acids-producing Gram-positive bacteriaActa Pharmaceutica Sinica B, 2023
- Alteration of gut microbiota in acute pancreatitis and associated therapeutic strategiesBiomedicine & Pharmacotherapy, 2021
- Acute PancreatitisJAMA, 2021
- Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitisBiomedicine & Pharmacotherapy, 2020
- Development of a RecE/T‐Assisted CRISPR–Cas9 Toolbox for LactobacillusBiotechnology Journal, 2019
- Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and miceJournal of Gastroenterology, 2018
- Normalization of Host Intestinal Mucus Layers Requires Long-Term Microbial ColonizationCell Host & Microbe, 2015
- Denitrifying sulfide removal process on high-salinity wastewaters in the presence of Halomonas sp.Applied Microbiology and Biotechnology, 2015
- Meta-analysis of gut barrier dysfunction in patients with acute pancreatitisBritish Journal of Surgery, 2014
- Low activity of LSD1 elicits a pro-inflammatory gene expression profile in riboflavin-deficient human T Lymphoma Jurkat cellsGenes & Nutrition, 2014